Baicalein increases the cytotoxicity of cisplatin by enhancing gap junction intercellular communication

Wang,Yiwen; Wang,Qin; Zhang,Suzhi; Zhang,Yuan; Tao,Liang

doi:10.3892/mmr.2014.2157

Baicalein increases the cytotoxicity of cisplatin by enhancing gap junction intercellular communication

Authors:
- Yiwen Wang
- Qin Wang
- Suzhi Zhang
- Yuan Zhang
- Liang Tao
View Affiliations

Affiliations: Department of Pharmacy, Sun Yat‑Sen Memorial Hospital, Sun Yat‑Sen University, Guangzhou, Guangdong 510120, P.R. China, Department of Pharmacology, Zhongshan School of Medicine, Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: April 16, 2014 https://doi.org/10.3892/mmr.2014.2157
Pages: 515-521

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Drug resistance limits the clinical application of cisplatin, a widely used chemotherapeutic agent. Gap junction (GJ) is a channel that enhances cytotoxicity of certain chemotherapeutic agents. Baicalein is well known for its antitumor activity. This study investigated the effect of baicalein on cisplatin cytotoxicity and the relationship between this effect and the modulation of the GJ function in connexin 26 (Cx26)‑transfected HeLa cells. The sulforhodamine B (SRB) assay was used to examine the effect of baicalein on cell viability. A ‘parachute’ assay was used to investigate the effect of baicalein on GJ function. The effects of baicalein on cisplatin cytotoxicity and GJ function were assayed by standard colony‑forming assays. The expression of Cx26 was monitored by western blotting. It was observed that exposure of Cx26‑transfected cells to cisplatin reduced the number of colonies formed in low‑density cultures (no GJ formation) and in high‑density cultures (GJ formation), but the toxic effect was greater when cells were seeded at a high density. In the absence of connexin expression or with blockage of connexin channels however, cell density had no effect on cisplatin toxicity. Baicalein significantly enhanced cisplatin cytotoxicity, but this effect required the presence of functional GJs between the cells. In conclusion, the dependence of cisplatin toxicity on cell density is mediated by GJs. Baicalein increases cisplatin cytotoxicity through enhancing GJ intercellular communication.

View Figures

View References

1	Giaccone G: Clinical perspectives on platinum resistance. Drugs. 59(Suppl 4): 9–17. 2000. View Article : Google Scholar
2	Fuertes MA, Alonso C and Pérez JM: Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev. 103:645–662. 2003. View Article : Google Scholar : PubMed/NCBI
3	King TJ and Bertram JS: Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta. 1719:146–160. 2005. View Article : Google Scholar : PubMed/NCBI
4	Kalvelyte A, Imbrasaite A, Bukauskiene A, Verselis VK and Bukauskas FF: Connexins and apoptotic transformation. Biochem Pharmacol. 66:1661–1672. 2003. View Article : Google Scholar : PubMed/NCBI
5	Jensen R and Glazer PM: Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci USA. 101:6134–6139. 2004. View Article : Google Scholar : PubMed/NCBI
6	Wang Q, You T, Yuan D, Han X, Hong X, He B, Wang L, Tong X, Tao L and Harris AL: Cisplatin and oxaliplatin inhibit gap junctional communication by direct action and by reduction of connexin expression, thereby counteracting cytotoxic efficacy. J Pharmacol Exp Ther. 333:903–911. 2010. View Article : Google Scholar
7	Chaumontet C, Bex V, Gaillard-Sanchez I, Seillan-Heberden C, Suschetet M and Martel P: Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis. 15:2325–2330. 1994. View Article : Google Scholar : PubMed/NCBI
8	Conklin CM, Bechberger JF, MacFabe D, Guthrie N, Kurowska EM and Naus CC: Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis. 28:93–100. 2007. View Article : Google Scholar : PubMed/NCBI
9	Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
10	Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, Chang NW and Lin C: Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol Appl Pharmacol. 263:360–367. 2012. View Article : Google Scholar : PubMed/NCBI
11	Takahashi H, Chen MC, Pham H, Angst E, King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, Hines OJ, Gukovskaya AS, Go VL and Eibl G: Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta. 1813:1465–1474. 2011.
12	Chen CH, Huang TS, Wong CH, Hong CL, Tsai YH, Liang CC, Lu FJ and Chang WH: Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 cells. Food Chem Toxicol. 47:638–644. 2009. View Article : Google Scholar : PubMed/NCBI
13	Zhang Y, Song L, Cai L, Wei R, Hu H and Jin W: Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells. Food Chem Toxicol. 53:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
14	Koreen IV, Elsayed WA, Liu YJ and Harris AL: Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells. Biochem J. 383:111–119. 2004. View Article : Google Scholar
15	Papazisis KT, Geromichalos GD, Dimitriadis KA and Kortsaris AH: Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods. 208:151–158. 1997. View Article : Google Scholar : PubMed/NCBI
16	Goldberg GS, Bechberger JF and Naus CC: A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques. 18:490–497. 1995.PubMed/NCBI
17	Erdlenbruch B, Nier M, Kern W, Hiddemann W, Pekrun A and Lakomek M: Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients. Eur J Clin Pharmacol. 57:393–402. 2001. View Article : Google Scholar : PubMed/NCBI
18	Guan X, Cravatt BF, Ehring GR, Hall JE, Boger DL, Lerner RA and Gilula NB: The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J Cell Biol. 139:1785–1792. 1997. View Article : Google Scholar : PubMed/NCBI
19	Krysko DV, Leybaert L, Vandenabeele P and D’Herde K: Gap junctions and the propagation of cell survival and cell death signals. Apoptosis. 10:459–469. 2005. View Article : Google Scholar : PubMed/NCBI
20	Mesnil M, Piccoli C and Yamasaki H: A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res. 57:2929–2932. 1997.PubMed/NCBI
21	Tanaka M, Fraizer GC, De La Cerda J, Cristiano RJ, Liebert M and Grossman HB: Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery. Gene Ther. 8:139–148. 2001. View Article : Google Scholar : PubMed/NCBI
22	Garcia-Rodríguez L, Pérez-Torras S, Carrió M, Cascante A, García-Ribas I, Mazo A and Fillat C: Connexin-26 is a key factor mediating gemcitabine bystander effect. Mol Cancer Ther. 10:505–517. 2011.PubMed/NCBI
23	Li DR, Zhang W, Tang DP, Tu WS and Qin J: A study of the reverse effect of scutellarein on multidrug-resistant human ovarian carcinoma cell line A2780/ADM. Tumor. 24:111–113. 2004.
24	Lampe PD and Lau AF: The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol. 36:1171–1186. 2004. View Article : Google Scholar : PubMed/NCBI
25	Warn-Cramer BJ and Lau AF: Regulation of gap junctions by tyrosine protein kinases. Biochim Biophys Acta. 1662:81–95. 2004. View Article : Google Scholar : PubMed/NCBI
26	Traub O, Look J, Dermietzel R, Brümmer F, Hülser D and Willecke K: Comparative characterization of the 21-kD and 26-kD gap junction proteins in murine liver and cultured hepatocytes. J Cell Biol. 108:1039–1051. 1989. View Article : Google Scholar : PubMed/NCBI
27	Sáez JC, Nairn AC, Czernik AJ, Spray DC, Hertzberg EL, Greengard P and Bennett MV: Phosphorylation of connexin 32, a hepatocyte gap-junction protein, by cAMP-dependent protein kinase, protein kinase C and Ca²⁺/calmodulin-dependent protein kinase II. Eur J Biochem. 192:263–273. 1990.PubMed/NCBI
28	Chaumontet C, Droumaguet C, Bex V, Heberden C, Gaillard-Sanchez I and Martel P: Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. Cancer Lett. 114:207–210. 1997. View Article : Google Scholar
29	Huard C, Druesne N, Guyonnet D, Thomas M, Pagniez A, Le Bon AM, Martel P and Chaumontet C: Diallyl disulfide (DADS) enhances gap-junctional intercellular communication by both direct and indirect mechanisms in rat liver cells. Carcinogenesis. 25:91–98. 2004. View Article : Google Scholar : PubMed/NCBI